Product NDC: | 0093-0673 |
Proprietary Name: | Betamethasone Valerate |
Non Proprietary Name: | Betamethasone Valerate |
Active Ingredient(s): | 1 mg/g & nbsp; Betamethasone Valerate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-0673 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018642 |
Marketing Category: | NDA |
Start Marketing Date: | 19900930 |
Package NDC: | 0093-0673-15 |
Package Description: | 15 g in 1 TUBE (0093-0673-15) |
NDC Code | 0093-0673-15 |
Proprietary Name | Betamethasone Valerate |
Package Description | 15 g in 1 TUBE (0093-0673-15) |
Product NDC | 0093-0673 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Betamethasone Valerate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 19900930 |
Marketing Category Name | NDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | BETAMETHASONE VALERATE |
Strength Number | 1 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |